Raffles Medical posts 63.8% drop in H2 profit to S$30.3 million; looks to China, Japan growth
RAFFLES Medical Group posted a 63.8 per cent drop in net profit to S$30.3 million for the second half ended Dec 31, 2023, from S$83.7 million in the previous corresponding period.
The group attributed the weaker performance to the discontinuation of Covid-19-related activities in FY2023, it said on Monday (Feb 26).
The results translate to earnings per share (EPS) of 1.63 Singapore cents against EPS of 4.51 cents previously.
TRENDING NOW
Singapore developer in limbo after Timor-Leste scraps major township project
From hawker stall to Enterprise Award winner: How Han Keen Juan scaled the Old Chang Kee empire
‘I feel so stupid’: How young Indonesians get stuck on the debt treadmill
Hanoi orders 20% surge in IP enforcement cases in May after US warning